[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Tomsk Cardiology Research Institute\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":99},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,45,73],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":28,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":33,"lastUpdatePostDateStruct":34,"startDateStruct":37,"completionDateStruct":39,"leadSponsor":41,"locationsCount":44},"100635458","radial-vs-vena-no-touch-assessment-100635458",false,"NCT07552948","Radial vs Vena No-Touch Assessment","A Comparative Study of the Effectiveness of Radial Artery and No-touch Vein in Coronary Artery Bypass Grafting in Women","RAVENTA","Inclusion Criteria:\n\n1. Three-vessel disease involving the target circumflex artery with stenosis ≥70% and a diameter ≥1.5 mm\n2. Females aged 18 years and older\n3. Signed informed consent\n4. Clinical indications for coronary revascularization (refractory angina\u002Ftransient myocardial ischemia according to noninvasive tests)\n\nExclusion Criteria:\n\n1. Previous cardiac surgery of any type, including CABG\n2. Combined procedures\n3. Ineligibility for venous or radial artery harvesting as determined by preoperative Doppler flowmetry or clinical examination that would compromise graft patency.\n4. Acute myocardial ischemia\n5. EF less than 35%\n6. CKD 4.5\n7. Inability to understand the nature, scope, and consequences of the clinical trial, or to provide written informed consent due to cognitive impairment or mental illness.\n8. Life expectancy less than 1 year due to non-cardiac diseases.","FEMALE","18 Years",{"count":20,"type":21},110,"ESTIMATED","INTERVENTIONAL",[24],"NA","This study examines the outcomes of coronary artery bypass grafting (CABG) in women at 1 year after surgery. A randomized controlled trial is planned, including a comparative analysis of two observed groups depending on the chosen conduit for revascularization of the circumflex artery. The main group is supposed to include 55 patients undergoing CABG with the use of the radial artery, while the control group will include 55 patients undergoing CABG with the use of the great saphenous vein prepared using the no-touch technique.",[27],"Coronary Artery Atherosclerosis",[29,30,31],"Coronary artery atherosclerosis","no-touch vein","radial artery","RECRUITING","2026-04-22",{"date":35,"type":36},"2026-04-27","ACTUAL",{"date":38,"type":36},"2026-04-06",{"date":40,"type":21},"2029-04",{"name":42,"class":43},"Tomsk Cardiology Research Institute","OTHER",1,{"id":46,"slug":47,"hasResults":11,"nctId":48,"briefTitle":49,"officialTitle":50,"acronym":4,"eligibilityCriteria":51,"healthyVolunteers":11,"sex":52,"minAge":18,"maxAge":53,"enrollmentInfo":54,"targetDuration":4,"studyType":22,"phases":56,"briefSummary":57,"conditions":58,"keywords":60,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":65,"lastUpdatePostDateStruct":66,"startDateStruct":68,"completionDateStruct":70,"leadSponsor":72,"locationsCount":44},"100622623","full-sternotomy-vs-mini-sternotomy-for-ascending-aortic-pathology-100622623","NCT07386028","Full Sternotomy vs Mini-sternotomy for Ascending Aortic Pathology","Full Sternotomy Versus J-shaped Mini-sternotomy for Chronic Ascending Aortic Pathology","Inclusion Criteria:\n\n* Signed informed consent.\n* Ascending aorta greater than 5 cm without involving the aortic arch\n\nExclusion Criteria:\n\n* Acute aortic dissection or urgent\u002Femergent cases.\n* Redo aortic surgery.\n* Aortic arch surgery.\n* Concomitant CABG or left ventricle restoration","ALL","80 Years",{"count":55,"type":21},200,[24],"This study investigates outcomes after hemiarch repair in patients with chronic ascending aortic disease. The patients will be divided into two groups according to surgical approach: 100 patients will undergo hemiarch repair via full sternotomy (FS group) and 100 patients will receive hemiarch repair via J-shaped mini-sternotomy (MS group). Early and late outcomes will be recorded.",[59],"Ascending Aortic Aneurysm",[61,62,63,64],"ascending aortic aneurysm","aortic replacement","sternotomy","mini-sternotomy","2026-02-03",{"date":67,"type":36},"2026-02-05",{"date":69,"type":36},"2022-07-10",{"date":71,"type":21},"2027-12",{"name":42,"class":43},{"id":74,"slug":75,"hasResults":11,"nctId":76,"briefTitle":77,"officialTitle":78,"acronym":79,"eligibilityCriteria":80,"healthyVolunteers":11,"sex":52,"minAge":18,"maxAge":4,"enrollmentInfo":81,"targetDuration":4,"studyType":22,"phases":83,"briefSummary":85,"conditions":86,"keywords":4,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":91,"lastUpdatePostDateStruct":92,"startDateStruct":94,"completionDateStruct":96,"leadSponsor":98,"locationsCount":44},"100577470","phase-4-the-effect-of-colchicine-on-the-occurrence-of-atrial-fibrillation-after-cardiac-surgery-100577470","NCT06798714","The Effect of Colchicine on the Occurrence of Atrial Fibrillation After Cardiac Surgery","The Effect of Colchicine on the Occurrence of Atrial Fibrillation After Cardiac Surgery (CAFE)","CAFE","Inclusion Criteria:\n\n1. Elective coronary artery bypass grafting on pump;\n2. signed informed consent to participate in the study.\n\nExclusion Criteria:\n\n1. Reduced left ventricular ejection fraction (≤35%);\n2. Valvular heart disease requiring surgical correction;\n3. Liver failure with an increase in liver transaminases ≥1.5 times;\n4. Renal failure (GFR\\\u003C35 mL\u002Fmin\u002F1.73 m2 calculated with CKD-EPI);\n5. Permanent, persistent or paroxysmal atrial fibrillation;\n6. Previously implanted pacemaker;\n7. Hypersensitivity to colchicine;\n8. Neutropenia;\n9. History of alcoholism;\n10. Refusal to sign informed consent",{"count":82,"type":21},140,[84],"PHASE4","Development of a new comprehensive method for perioperative prevention of atrial fibrillation paroxysms in cardiac surgery patients at the hospital stage.\n\nIt is planned to recruit 70 patients who will undergo pericardial fenestration during the operation using the original technique during coronary artery bypass grafting (Patent No. 2647626 C1 Russian Federation), and will be prescribed colchicine (the drug \"Colchicum-dispert\") in the perioperative period in order to prevent the development of paroxysms of atrial fibrillation in the postoperative period, and 70 cardiac surgery patients operated on using the standard technique (without performing the pericardial fenestration procedure intraoperatively), receiving non-steroidal anti-inflammatory drugs in the postoperative period.",[87,88,89,90],"Coronary Artery Disease","Atrial Fibrillation","Coronary Artery Bypass Grafting","Colchicine","2025-09-02",{"date":93,"type":36},"2025-09-09",{"date":95,"type":36},"2025-01-20",{"date":97,"type":21},"2026-02-20",{"name":42,"class":43},""]